1. Home
  2. GANX vs SND Comparison

GANX vs SND Comparison

Compare GANX & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • SND
  • Stock Information
  • Founded
  • GANX 2017
  • SND 2011
  • Country
  • GANX United States
  • SND United States
  • Employees
  • GANX N/A
  • SND N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • GANX Health Care
  • SND Industrials
  • Exchange
  • GANX Nasdaq
  • SND Nasdaq
  • Market Cap
  • GANX 69.0M
  • SND 75.7M
  • IPO Year
  • GANX 2021
  • SND 2016
  • Fundamental
  • Price
  • GANX $1.64
  • SND $1.88
  • Analyst Decision
  • GANX Strong Buy
  • SND
  • Analyst Count
  • GANX 5
  • SND 0
  • Target Price
  • GANX $8.20
  • SND N/A
  • AVG Volume (30 Days)
  • GANX 614.4K
  • SND 82.2K
  • Earning Date
  • GANX 11-13-2025
  • SND 11-11-2025
  • Dividend Yield
  • GANX N/A
  • SND 5.32%
  • EPS Growth
  • GANX N/A
  • SND N/A
  • EPS
  • GANX N/A
  • SND 0.02
  • Revenue
  • GANX N/A
  • SND $305,848,000.00
  • Revenue This Year
  • GANX N/A
  • SND N/A
  • Revenue Next Year
  • GANX N/A
  • SND N/A
  • P/E Ratio
  • GANX N/A
  • SND $92.04
  • Revenue Growth
  • GANX N/A
  • SND 3.43
  • 52 Week Low
  • GANX $1.36
  • SND $1.76
  • 52 Week High
  • GANX $3.19
  • SND $2.80
  • Technical
  • Relative Strength Index (RSI)
  • GANX 43.33
  • SND 43.13
  • Support Level
  • GANX $1.55
  • SND $1.89
  • Resistance Level
  • GANX $1.78
  • SND $1.99
  • Average True Range (ATR)
  • GANX 0.13
  • SND 0.05
  • MACD
  • GANX -0.03
  • SND -0.01
  • Stochastic Oscillator
  • GANX 18.00
  • SND 0.00

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

Share on Social Networks: